Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Moscinski

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Oncogene|February 1, 1988
Myeloperoxidase and oncogene expression in GM-CSF induced bone marrow differentiationB D Jaffe, D E Sabath, G D Johnson, et al.
Oncogene|October 18, 2011
Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomasX Zhang, X Chen, J Lin, et al.
Leukemia|October 23, 2010
Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomasJ Lin, T Lwin, J-J Zhao, et al.
British Journal of Haematology|March 1, 1997
Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC-IE): a novel, intensive induction chemotherapy regimen for patients with high-risk multiple myelomaO F Ballester, L C Moscinski, K K Fields, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Oncogene|February 1, 1988
Myeloperoxidase and oncogene expression in GM-CSF induced bone marrow differentiationB D Jaffe, D E Sabath, G D Johnson, et al.
Oncogene|October 18, 2011
Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomasX Zhang, X Chen, J Lin, et al.
Leukemia|October 23, 2010
Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomasJ Lin, T Lwin, J-J Zhao, et al.
British Journal of Haematology|March 1, 1997
Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC-IE): a novel, intensive induction chemotherapy regimen for patients with high-risk multiple myelomaO F Ballester, L C Moscinski, K K Fields, et al.
Pageof 5